WASHINGTON — Senior administration officials are promising that Friday afternoon, President Trump will roll out “the most comprehensive plan to tackle prescription drug affordability of any president.”

But ahead of his 2 p.m. remarks, the White House is keeping the actual plans under wraps — only hinting at the kinds of new policies that might come out in a “blueprint,” to be released alongside the speech and entitled “American Patients First.” In a late Thursday call with reporters, two senior administration officials largely deflected questions about exactly what’s to come in that blueprint, or in a separate “request for information” — an early regulatory outline of proposals — that will also accompany the remarks.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy